Stock listing

A2DQES Stock Price, News, Filings & Events — Thalia Therapeutics Plc

Selected listing: A2DQES · LSX · EUR · DE

This page tracks Thalia Therapeutics Plc's A2DQES:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQES:LSX. A2DQES:LSX is the stock-level entry point for investors researching Thalia Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.

A2DQES:LSXEURDEUpdated August 22, 2026
Thalia Therapeutics Plc logo
Ticker
A2DQES:LSX
Asset type
Stock
Market cap
$21.9M
Sector
Health Technology
Industry
Biotechnology
Exchange
LSX
Currency
EUR

Thalia Therapeutics Plc A2DQES:LSX stock context

This page tracks Thalia Therapeutics Plc's A2DQES:LSX listing on LSX in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A2DQES:LSX. A2DQES:LSX is the stock-level entry point for investors researching Thalia Therapeutics Plc, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.

Latest news from Thalia Therapeutics Plc

All Thalia Therapeutics Plc news →

Thalia Therapeutics Plc earnings calls

Research Thalia Therapeutics Plc

Alternate listings